期刊文献+

应用Alamar Blue法与试管法测定α-倒捻子素和8-甲氧基补骨脂素体外抗结核杆菌活性 被引量:3

Application of Alamar Blue and two folds dilutions methods for determining in vitro antimycobacterial activity of α-mangostin and 8-methoxypsoralen
下载PDF
导出
摘要 选取传统中药提取单体化合物α-倒捻子素和8-甲氧基补骨脂素,通过2种药物敏感性实验方法MABA(Microdilution Alamar Blue Assay)分析与试管法分别测定了两种化合物对结核分枝杆菌H37Rv(ATCC27294)和H37Ra(ATCC25177)的体外抗菌活性,同时还测定了9种阳性抗结核药物对这两种结核菌的最低抑菌浓度(MIC),比较2种方法的检测结果。结果表明:α-倒捻子素对结核分枝杆菌H37Rv(ATCC27294)和H37Ra(ATCC25177)的最低抑菌浓度均为6.25μg/mL,而8-甲氧基补骨脂素对结核分枝杆菌H37Rv(ATCC27294)和H37Ra(ATCC25177)的最低抑菌浓度均为128μg/mL。Alamar B1ue法与试管法相比较,完全符合率是90%(9/11),具有较好的一致性。本研究结果表明Mamar B1ue法是一种快速、简便测定药物对结核分枝杆菌MIC的方法。本研究为α-倒捻子素和8-甲氧基补骨脂素的进一步开发利用和抗分枝杆菌机制研究打下了基础。 α-mangostin and 8-methoxypsoralen (8-MOP) are active constituents from typical traditional Chinese medicine Garcinia mangostana L.and Psoralea corylifolia L., respectively. The antimycobacterial susceptibility ofα -mangostin and 8-MOP were determined by the microdilution alamar blue Assay (MABA) and the conventional two folds dilutions method against Mycobacterium tuberculosis (M. tuberculosis) H37Rv (ATCC 27294) and M. tuberculosis H37Ra (ATCC 25177), α-mangostin showed a minimal inhibitory concentration (MIC) of 6.25 μg/mL against M. tuberculosis H37Rv and M. tuberculosis H37Ra, and 8-MOP showed a minimal inhibitory concentration (MIC) of 128 μg/mL against M. tuberculosis H37Rv and M. tuberculosis H37Ra. These results will pave the way to further development and exploring the mechanism of α-mangostin and 8-MOP against mycobacterium.
出处 《中国预防兽医学报》 CAS CSCD 北大核心 2010年第1期71-73,共3页 Chinese Journal of Preventive Veterinary Medicine
基金 国家973计划(2006CB504402)
关键词 α-倒捻子素 8-甲氧基补骨脂素 结核分枝杆菌 最低抑菌浓度 活性 α-mangostin 8-methoxypsoralen Mycobacterium tuberculosis minimal inhibitory concentration activity
  • 相关文献

参考文献13

  • 1WHO Report. Global tuberculosis control-surveillance, planning financing [R]. WHO/HTM/TB/2007.376.Geneva, Switzerland: WHO, 2007.
  • 2World Health Organisation. Anti-tuberculosis drug resistance in the world. Report no. 2: prevalence and trends [R]. WHO/CDS/ TB/2000. 278. Geneva, Switzerland: WHO, 2000.
  • 3蒋锦琴,黄卫平,张小贤,周海鸥,严杰.中药结核丸对结核分枝杆菌体内外抗菌效果的观察[J].江西医学检验,2005,23(6):521-522. 被引量:18
  • 4吴虢东,王玲.抗结核中药的研究进展[J].医学综述,2007,13(6):475-477. 被引量:28
  • 5卢润生,郑德福,李定越,杨筠,邓大志,陈秋.某中药抗结核菌药物效果实验研究[J].现代预防医学,2007,34(5):878-879. 被引量:6
  • 6Ong H C, Nordiana M. Malay ethno-medico botany in Machang, Kelantan, Malaysia [J]. Fitoterapia, 1999, 70(50): 502.
  • 7Suksamram S, Suwannapoch N. Xanthones from the green fruit hulls of Garcinia mangostana [J]. J Nat Prod, 2002, 65(5): 761.
  • 8Harrison L J. Xanthones from the heartwood of Garcinia mangostana [J]. Phytochemistry, 2002, 60(5): 541.
  • 9金万宝,吴红,关福兰,孟胜男.8-甲氧基补骨脂素对大鼠离体肺动脉的选择性抑制作用[J].中国医科大学学报,1999,28(4):250-252. 被引量:5
  • 10Figueroa M, Rivero-Cruz I, Rivero-Cruz B, et al. Constituents, biological activities and quality control parameters of the crude extract and essential oil from Arracacia tolucensis var. multifida [J]. J Ethnopharmacol, 2007, 113:125-131.

二级参考文献38

共引文献54

同被引文献109

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部